Hearscape
Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)
148Status checked
135Strong
320Backlog
More filters and sort (1 active)
9 records in Main database · 8 strong · 8 status checked
Otarmeni by Regeneron
Regeneron Pharmaceuticals · Gene Therapy · Approved
ApprovedTherapeuticStronger sources
Evidence
regulatory
Confidence
99%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss
Population
PediatricAdultCongenitalGenetic
Details
AK-OTOF by Eli Lilly and Akouos
Eli Lilly and Company · Gene Therapy · Phase 2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
95%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss
Population
PediatricAdultCongenitalGenetic
Details
SENS-501 by Sensorion
Sensorion · Gene Therapy · Phase 1/2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
94%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss
Population
PediatricCongenitalGeneticOTOF / DFNB9
Details
Rincell-1 by Rinri Therapeutics
Rinri Therapeutics · Cell Therapy · Phase 1/2
ActiveTherapeuticStronger sources
Evidence
trial
Confidence
92%
Indications
Hearing LossSensorineural Hearing LossAge-Related Hearing LossAuditory Neuropathy
Population
AdultAge-RelatedAuditory Neuropathy
Details
Cochlear Nucleus ABI541 Brainstem Implant
Cochlear · BCI/Neurotech · Approved
ApprovedDeviceAuditory BCI / NeurotechStronger sources
Evidence
regulatory
Confidence
95%
Indications
Hearing LossAuditory Neuropathy
Population
AdultPost-LingualProfound
Details
PATH MEDICAL SENTIERO ADVANCED
PATH MEDICAL · Diagnostic · Marketed
MarketedDiagnosticDiagnosticsStronger sources
Evidence
regulatory
Confidence
91%
Indications
Hearing LossAuditory NeuropathyVestibular Disorders
Population
AdultPediatricCongenitalClinical Audiology
Details
MED-EL SYNCHRONY ABI Auditory Brainstem Implant
MED-EL · BCI/Neurotech · Approved
ApprovedDeviceAuditory BCI / NeurotechStronger sources
Evidence
company
Confidence
89%
Indications
Hearing LossAuditory NeuropathyCongenital Hearing Loss
Population
AdultPediatricCongenitalProfound
Details
ReSonance by Lineage Cell Therapeutics
Lineage Cell Therapeutics · Cell Therapy · Preclinical
ActiveTherapeuticStronger sources
Evidence
company
Confidence
87%
Indications
Hearing LossSensorineural Hearing LossAuditory Neuropathy
Population
AdultAuditory Neuropathy
Details
EHT102 by EuHearing
Shanghai EuHearing Therapeutics Co., Ltd · Gene Therapy · Phase 1/2
ActiveTherapeutic
Evidence
trial
Confidence
90%
Indications
Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss
Population
PediatricGeneticCongenitalOTOF / DFNB9
Details